TY - JOUR A1 - Gottschalk, Michael G. A1 - Richter, Jan A1 - Ziegler, Christiane A1 - Schiele, Miriam A. A1 - Mann, Julia A1 - Geiger, Maximilian J. A1 - Schartner, Christoph A1 - Homola, György A. A1 - Alpers, Georg W. A1 - Büchel, Christian A1 - Fehm, Lydia A1 - Fydrich, Thomas A1 - Gerlach, Alexander L. A1 - Gloster, Andrew T. A1 - Helbig-Lang, Sylvia A1 - Kalisch, Raffael A1 - Kircher, Tilo A1 - Lang, Thomas A1 - Lonsdorf, Tina B. A1 - Pané-Farré, Christiane A. A1 - Ströhle, Andreas A1 - Weber, Heike A1 - Zwanzger, Peter A1 - Arolt, Volker A1 - Romanos, Marcel A1 - Wittchen, Hans-Ulrich A1 - Hamm, Alfons A1 - Pauli, Paul A1 - Reif, Andreas A1 - Deckert, Jürgen A1 - Neufang, Susanne A1 - Höfler, Michael A1 - Domschke, Katharina T1 - Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes JF - Translational Psychiatry N2 - Preclinical studies point to a pivotal role of the orexin 1 (OX1) receptor in arousal and fear learning and therefore suggest the HCRTR1 gene as a prime candidate in panic disorder (PD) with/without agoraphobia (AG), PD/AG treatment response, and PD/AG-related intermediate phenotypes. Here, a multilevel approach was applied to test the non-synonymous HCRTR1 C/T Ile408Val gene variant (rs2271933) for association with PD/AG in two independent case-control samples (total n = 613 cases, 1839 healthy subjects), as an outcome predictor of a six-weeks exposure-based cognitive behavioral therapy (CBT) in PD/AG patients (n = 189), as well as with respect to agoraphobic cognitions (ACQ) (n = 483 patients, n = 2382 healthy subjects), fMRI alerting network activation in healthy subjects (n = 94), and a behavioral avoidance task in PD/AG pre- and post-CBT (n = 271). The HCRTR1 rs2271933 T allele was associated with PD/AG in both samples independently, and in their meta-analysis (p = 4.2 × 10−7), particularly in the female subsample (p = 9.8 × 10−9). T allele carriers displayed a significantly poorer CBT outcome (e.g., Hamilton anxiety rating scale: p = 7.5 × 10−4). The T allele count was linked to higher ACQ sores in PD/AG and healthy subjects, decreased inferior frontal gyrus and increased locus coeruleus activation in the alerting network. Finally, the T allele count was associated with increased pre-CBT exposure avoidance and autonomic arousal as well as decreased post-CBT improvement. In sum, the present results provide converging evidence for an involvement of HCRTR1 gene variation in the etiology of PD/AG and PD/AG-related traits as well as treatment response to CBT, supporting future therapeutic approaches targeting the orexin-related arousal system. KW - human behaviour KW - molecular neuroscience KW - personalized medicine KW - predictive markers KW - psychiatric disorders Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-227479 VL - 9 ER - TY - JOUR A1 - Rayner, Christopher A1 - Coleman, Jonathan R. I. A1 - Purves, Kirstin L. A1 - Hodsoll, John A1 - Goldsmith, Kimberley A1 - Alpers, Georg W. A1 - Andersson, Evelyn A1 - Arolt, Volker A1 - Boberg, Julia A1 - Bögels, Susan A1 - Creswell, Cathy A1 - Cooper, Peter A1 - Curtis, Charles A1 - Deckert, Jürgen A1 - Domschke, Katharina A1 - El Alaoui, Samir A1 - Fehm, Lydia A1 - Fydrich, Thomas A1 - Gerlach, Alexander L. A1 - Grocholewski, Anja A1 - Hahlweg, Kurt A1 - Hamm, Alfons A1 - Hedman, Erik A1 - Heiervang, Einar R. A1 - Hudson, Jennifer L. A1 - Jöhren, Peter A1 - Keers, Robert A1 - Kircher, Tilo A1 - Lang, Thomas A1 - Lavebratt, Catharina A1 - Lee, Sang-hyuck A1 - Lester, Kathryn J. A1 - Lindefors, Nils A1 - Margraf, Jürgen A1 - Nauta, Maaike A1 - Pané-Farré, Christiane A. A1 - Pauli, Paul A1 - Rapee, Ronald M. A1 - Reif, Andreas A1 - Rief, Winfried A1 - Roberts, Susanna A1 - Schalling, Martin A1 - Schneider, Silvia A1 - Silverman, Wendy K. A1 - Ströhle, Andreas A1 - Teismann, Tobias A1 - Thastum, Mikael A1 - Wannemüller, Andre A1 - Weber, Heike A1 - Wittchen, Hans-Ulrich A1 - Wolf, Christiane A1 - Rück, Christian A1 - Breen, Gerome A1 - Eley, Thalia C. T1 - A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders JF - Translational Psychiatry N2 - Major depressive disorder and the anxiety disorders are highly prevalent, disabling and moderately heritable. Depression and anxiety are also highly comorbid and have a strong genetic correlation (r(g) approximate to 1). Cognitive behavioural therapy is a leading evidence-based treatment but has variable outcomes. Currently, there are no strong predictors of outcome. Therapygenetics research aims to identify genetic predictors of prognosis following therapy. We performed genome-wide association meta-analyses of symptoms following cognitive behavioural therapy in adults with anxiety disorders (n = 972), adults with major depressive disorder (n = 832) and children with anxiety disorders (n = 920; meta-analysis n = 2724). We (h(SNP)(2)) and polygenic scoring was used to examine genetic associations between therapy outcomes and psychopathology, personality and estimated the variance in therapy outcomes that could be explained by common genetic variants learning. No single nucleotide polymorphisms were strongly associated with treatment outcomes. No significant estimate of h(SNP)(2) could be obtained, suggesting the heritability of therapy outcome is smaller than our analysis was powered to detect. Polygenic scoring failed to detect genetic overlap between therapy outcome and psychopathology, personality or learning. This study is the largest therapygenetics study to date. Results are consistent with previous, similarly powered genome-wide association studies of complex traits. KW - Human behaviour KW - Personalized medicine KW - Prognostic markers KW - Psychiatric disorders Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-225048 VL - 9 IS - 150 ER - TY - THES A1 - Lang, Thomas C. T1 - Quantum Monte Carlo methods and strongly correlated electrons on honeycomb structures T1 - Quanten Monte Carlo Methoden und stark korrelierte Elektronen auf hexagonalen Strukturen N2 - In this thesis we apply recently developed, as well as sophisticated quantum Monte Carlo methods to numerically investigate models of strongly correlated electron systems on honeycomb structures. The latter are of particular interest owing to their unique properties when simulating electrons on them, like the relativistic dispersion, strong quantum fluctuations and their resistance against instabilities. This work covers several projects including the advancement of the weak-coupling continuous time quantum Monte Carlo and its application to zero temperature and phonons, quantum phase transitions of valence bond solids in spin-1/2 Heisenberg systems using projector quantum Monte Carlo in the valence bond basis, and the magnetic field induced transition to a canted antiferromagnet of the Hubbard model on the honeycomb lattice. The emphasis lies on two projects investigating the phase diagram of the SU(2) and the SU(N)-symmetric Hubbard model on the hexagonal lattice. At sufficiently low temperatures, condensed-matter systems tend to develop order. An exception are quantum spin-liquids, where fluctuations prevent a transition to an ordered state down to the lowest temperatures. Previously elusive in experimentally relevant microscopic two-dimensional models, we show by means of large-scale quantum Monte Carlo simulations of the SU(2) Hubbard model on the honeycomb lattice, that a quantum spin-liquid emerges between the state described by massless Dirac fermions and an antiferromagnetically ordered Mott insulator. This unexpected quantum-disordered state is found to be a short-range resonating valence bond liquid, akin to the one proposed for high temperature superconductors. Inspired by the rich phase diagrams of SU(N) models we study the SU(N)-symmetric Hubbard Heisenberg quantum antiferromagnet on the honeycomb lattice to investigate the reliability of 1/N corrections to large-N results by means of numerically exact QMC simulations. We study the melting of phases as correlations increase with decreasing N and determine whether the quantum spin liquid found in the SU(2) Hubbard model at intermediate coupling is a specific feature, or also exists in the unconstrained t-J model and higher symmetries. N2 - Wir untersuchen mit Hilfe von neu entwickelten sowie technisch ausgereiften Quanten-Monte-Carlo Methoden Modelle stark korrelierter Elektronen auf hexagonalen Gittern. Letztere zeichnen sich durch die einzigartigen Eigenschaften der auf ihnen simulierten Elektronen aus, wie zum Beispiel deren relativistische Dispersionsrelation, die starken Quantenfluktuationen und deren Beständigkeit gegenüber Instabilitäten. Diese Arbeit umfasst mehrere Projekte, einschließlich der Erweiterung des weak-coupling continuous time Quanten-Monte-Carlo Verfahrens und dessen Anwendung auf Phononen-Systeme und den Null-Temperatur Grundzustand, der Studie eines Quanten-Phasenübergangs in einem Kristall mit dominanter Valenzbindung in einem Spin-1/2 Heisenberg model mit vier-Spin Wechselwirkung, und der Untersuchung eines gekippten Antiferromagneten im Hubbard Model, induziert durch ein externes Magnetfeld. Die Schwerpunkte dieser Arbeit liegen bei zwei Studien der Phasendiagramme des SU(2) und SU(N)-symmetrischen Hubbard Models auf dem hexagonalen Gitter. Bei niedrigen Temperaturen haben Elektronen in Festkörpern die Tendenz, Ordnung zu entwickeln. Eine Ausnahme sind Quanten Spinflüssigkeiten, in denen Fluktuationen Ordnung selbst bei niedrigsten Temperaturen verhindern. Bislang war es nahezu unmöglich, diese in experimentell realistischen mikroskopischen Modellen zu finden und zu simulieren. In aufwändigen Quanten-Monte-Carlo Simulationen des SU(2) Hubbard Models konnten wir das Auftreten einer solchen Quanten Spinflüssigkeit zeigen, welche die Phasen der masselosen Dirac-Fermionen und eines antiferromagnetischem Isolators trennt. Dieser unerwartete, ungeordnete Quantenzustand weist kurzreichweitige Korrleationen ähnlich einer Resonanz-Valenzbond-Flüssigkeit auf, welche in Zusammenhang mit Hochtemperatur-Spuraleitung steht. Motiviert durch die reichhaltigen Phasendiagramme von SU(N)-symmetrischen Modellen, untersuchen wir mit Hilfe von Quanten-Monte Carlo-Simulationen den SU(N)-Hubbard-Heisenberg-Antiferromagneten auf dem hexagonalen Gitter in Bezug auf die Verlässlichkeit von 1/N Korrekturen von Molekularfeldnäherungen. Wir untersuchen das Schmelzen von Phasen als Funktion von abnehmendem N und bestimmen, ob die im SU(2)-Hubbard-Model gefundene Quanten-Spinflüssigkeit eine spezielle Eigenschaft dieses Modells ist, oder ob diese auch im erweiterten t-J Modell bei höheren Symmetrien gefunden werden kann. KW - Monte-Carlo-Simulation KW - Niederdimensionaler Festkörper KW - Hexagonaler Kristall KW - Elektronenstruktur KW - Starke Kopplung KW - Monte Carlo KW - Markov-Ketten-Monte-Carlo-Verfahren KW - Theoretische Physik KW - Niederdimensionaler Festkörper KW - Festkörpertheorie KW - Quantum Monte Carlo KW - Condensed matter theory Y1 - 2010 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-53506 ER - TY - JOUR A1 - Pachel, Christina A1 - Mathes, Denise A1 - Bayer, Barbara A1 - Dienesch, Charlotte A1 - Wangorsch, Gaby A1 - Heitzmann, Wolfram A1 - Lang, Isabell A1 - Ardehali, Hossein A1 - Ertl, Georg A1 - Dandekar, Thomas A1 - Wajant, Harald A1 - Frantz, Stefan T1 - Exogenous Administration of a Recombinant Variant of TWEAK Impairs Healing after Myocardial Infarction by Aggravation of Inflammation JF - PLoS ONE N2 - Background: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor fibroblast growth factorinducible 14 (Fn14) are upregulated after myocardial infarction (MI) in both humans and mice. They modulate inflammation and the extracellular matrix, and could therefore be important for healing and remodeling after MI. However, the function of TWEAK after MI remains poorly defined. Methods and results: Following ligation of the left coronary artery, mice were injected twice per week with a recombinant human serum albumin conjugated variant of TWEAK (HSA-Flag-TWEAK), mimicking the activity of soluble TWEAK. Treatment with HSA-Flag-TWEAK resulted in significantly increased mortality in comparison to the placebo group due to myocardial rupture. Infarct size, extracellular matrix remodeling, and apoptosis rates were not different after MI. However, HSA-Flag-TWEAK treatment increased infiltration of proinflammatory cells into the myocardium. Accordingly, depletion of neutrophils prevented cardiac ruptures without modulating all-cause mortality. Conclusion: Treatment of mice with HSA-Flag-TWEAK induces myocardial healing defects after experimental MI. This is mediated by an exaggerated neutrophil infiltration into the myocardium. KW - apoptosis KW - myocardial infarction KW - neutrophils KW - cytokines KW - inflammation KW - myocardium KW - heart KW - extracellular matrix Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-129889 VL - 8 IS - 11 ER - TY - JOUR A1 - Weber, Heike A1 - Scholz, Claus Jürgen A1 - Domschke, Katharina A1 - Baumann, Christian A1 - Klauke, Benedikt A1 - Jacob, Christian P. A1 - Maier, Wolfgang A1 - Fritze, Jürgen A1 - Bandelow, Borwin A1 - Zwanzger, Peter Michael A1 - Lang, Thomas A1 - Fehm, Lydia A1 - Ströhle, Andreas A1 - Hamm, Alfons A1 - Gerlach, Alexander L. A1 - Alpers, Georg W. A1 - Kircher, Tilo A1 - Wittchen, Hans-Ulrich A1 - Arolt, Volker A1 - Pauli, Paul A1 - Deckert, Jürgen A1 - Reif, Andreas T1 - Gender Differences in Associations of Glutamate Decarboxylase 1 Gene (GAD1) Variants with Panic Disorder N2 - Background: Panic disorder is common (5% prevalence) and females are twice as likely to be affected as males. The heritable component of panic disorder is estimated at 48%. Glutamic acid dehydrogenase GAD1, the key enzyme for the synthesis of the inhibitory and anxiolytic neurotransmitter GABA, is supposed to influence various mental disorders, including mood and anxiety disorders. In a recent association study in depression, which is highly comorbid with panic disorder, GAD1 risk allele associations were restricted to females. Methodology/Principal Findings: Nineteen single nucleotide polymorphisms (SNPs) tagging the common variation in GAD1 were genotyped in two independent gender and age matched case-control samples (discovery sample n = 478; replication sample n = 584). Thirteen SNPs passed quality control and were examined for gender-specific enrichment of risk alleles associated with panic disorder by using logistic regression including a genotype6gender interaction term. The latter was found to be nominally significant for four SNPs (rs1978340, rs3762555, rs3749034, rs2241165) in the discovery sample; of note, the respective minor/risk alleles were associated with panic disorder only in females. These findings were not confirmed in the replication sample; however, the genotype6gender interaction of rs3749034 remained significant in the combined sample. Furthermore, this polymorphism showed a nominally significant association with the Agoraphobic Cognitions Questionnaire sum score. Conclusions/Significance: The present study represents the first systematic evaluation of gender-specific enrichment of risk alleles of the common SNP variation in the panic disorder candidate gene GAD1. Our tentative results provide a possible explanation for the higher susceptibility of females to panic disorder. KW - Medizin Y1 - 2012 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-75830 ER - TY - THES A1 - Lang, Thomas T1 - Vergleich der rheologischen Qualität von Erythrozytenkonzentraten, gewonnen durch herkömmliche Vollblutspende oder Multikomponentenspende und Einfluß der Entnahmeverfahren auf ausgewählte rheologische Laborparameter und in-vivo-Mikrozirkulation des Spenders T1 - Comparison of the rheological quality of red cell concentrates extracted from conventional whole blood donation or multicomponent apheresis and examination of the influence of the extraction method on selected rheological laboratory parameters and in-vivo microcirculation of the donor N2 - 20 Probanden nahmen im prospektiven Paarvergleich im Abstand von mindestens 8 Wochen im cross-over-Verfahren an je einer Vollblutspende (VBS) und einer maschinellen Multikomponentenspende (MKS) teil. Die erzeugten leukozyten-depletierten Erythrozytenkonzentrate beider Gruppen wurden mittels CPD-50 antikoaguliert und über einen Zeitraum von 63 Tagen in PAGGS-Mannitol gelagert. Beurteilt wurden zum einen rheologische in-vitro-Parameter bei Spendern und Blutkonserven in zweiwöchentlichen Abständen: oszillierende Kapillarviskosimetrie, Erythrozytenaggregometrie und Filtrometrie. Zudem kam bei den Maschinenspendern die neue Methode der Laser-Doppler-Anemometrie zur Ermittlung der kapillären in-vivo-Blutflußgeschwindigkeit in Einzelkapillaren zur Anwendung. Konkordant kam es in beiden Gruppen zum Ansteigen der viskösen Viskosität der Erythrozytenkonzentrate mit überproportionalem Anstieg nach 7 Wochen Lagerung. Die elastische Viskosität stieg ebenfalls in beiden Gruppen an, hier wurden in der Gruppe der Vollblutspender bereits zu Beginn deutlich höhere Werte gemessen, welche in der Vergleichsgruppe erst nach 49 Tagen erreicht wurden. Bei den Blutspendern konnten 24 Stunden nach Spende Veränderungen von visköser und elastischer Viskosität gezeigt werden, welche stark mit Erythrozytenanzahl, Hämoglobin und Hämatokrit korrelierten. Bei konstanten Werten der dynamischen Erythrozytenaggregation zeigte die statische Erythrozytenaggregation bei den Vollblutspenden nach drei Wochen eine Zunahme, in der MKS-Gruppe imponierte ein biphasisches Verhalten mit initialer Abnahme der Lichttransmission. Unabhängig vom Spendeverfahren, trat eine deutliche Abnahme der Filtrierbarkeit der Produkte in beiden Gruppen in den letzten beiden Lagerungswochen auf. Eindrucksvoll war die Reduktion der Filterokklusionsrate auf unter 40 % des Ausgangswertes durch Leukozytenfiltration vor der Lagerung. Bereits 1 Stunde nach der Spende konnten filtrometrische Veränderungen bei den Spendern gezeigt werden, das Signifikanzniveau wurde hier nur knapp verfehlt. Die Bestimmung der kapillären Blutflußgeschwindigkeit zeigte eine Stunde nach Spende eine deutliche Abnahme auf 81 % des Ausgangswertes (p=0,064) in der Gruppe der Maschinenspender. Dies wird als Ausdruck einer diskreten Kreislaufbelastung durch das Aphereseverfahren gewertet. N2 - 20 test persons took part in the prospective pair-comparison at intervals of at least eight weeks in the cross-over method, consisting of one whole blood donation and one automated cytapheresis. The produced leukocyte-depleted red blood cell concentrates of both groups were anticoagulated via CPD-50 and stored in PAGGS-Mannitol for a period of 63 days. Rheological in-vitro parameters of the donors and the products were evaluated at intervals of two weeks: oscillating capillary viscosimetry, erythrocyte aggregometry and filtrometry. Furthermore the new method of laser-Doppler anemometry was implemented with the cytapheresis group in order to determine the capillary in-vivo blood flow velocity in single-capillaries. In both groups the viscous viscosity of the red blood cell concentrates increased by a disproportionately rise after seven weeks in storage. The elastic viscosity also increased in both groups. Notably higher values were gauged in the cytapheresis group already at the beginning, which were reached by the comparison group only after 49 days. 24 hours after the donation alterations of viscous and elastic viscosity of the donors’ blood could be observed, highly correlating with number of erythrocytes, hemoglobin and hematocrit. With the values of the dynamic erythrocyte aggregation remaining constant the static erythrocyte aggregation of whole blood donors showed an increase after three weeks. Within the automated cytapheresis group a biphasic behaviour with initial decrease of light transmission was noticeable. Independent of the donation method a significant decrease of the products’ filterability could be noted in both groups during the last two weeks in storage. The reduction of the clogging rate to below 40 % of the initial value by means of leukocyte filtration before putting the samples into storage was quite impressive. Filtrometric alterations within the donor groups could be verified only one hour after the donation. The level of significance was not reached here. In the automated cytapheresis group the capillary blood flow velocity showed a significant decrease to 81 % of its initial value (p=0,064) one hour after the donation. This is seen as the expression of a discrete strain on the donor’s circulation caused by the apheresis. KW - Blut KW - Erythrozyten KW - Rheologie KW - Apherese KW - Qualität KW - blood KW - erythrocyte KW - rheology KW - cytapheresis KW - quality Y1 - 2002 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-6055 ER - TY - JOUR A1 - Colvill, Emma A1 - Booth, Jeremy A1 - Nill, Simeon A1 - Fast, Martin A1 - Bedford, James A1 - Oelfke, Uwe A1 - Nakamura, Mitsuhiro A1 - Poulsen, Per A1 - Worm, Esben A1 - Hansen, Rune A1 - Ravkilde, Thomas A1 - Rydhög, Jonas Scherman A1 - Pommer, Tobias A1 - af Rosenschold, Per Munck A1 - Lang, Stephanie A1 - Guckenberger, Matthias A1 - Groh, Christian A1 - Herrmann, Christian A1 - Verellen, Dirk A1 - Poels, Kenneth A1 - Wang, Lei A1 - Hadsell, Michael A1 - Sothmann, Thilo A1 - Blanck, Oliver A1 - Keall, Paul T1 - A dosimetric comparison of real-time adaptive and non-adaptive radiotherapy: a multi-institutional study encompassing robotic, gimbaled, multileaf collimator and couch tracking JF - Radiotherapy and Oncology N2 - Purpose: A study of real-time adaptive radiotherapy systems was performed to test the hypothesis that, across delivery systems and institutions, the dosimetric accuracy is improved with adaptive treatments over non-adaptive radiotherapy in the presence of patient-measured tumor motion. Methods and materials: Ten institutions with robotic(2), gimbaled(2), MLC(4) or couch tracking(2) used common materials including CT and structure sets, motion traces and planning protocols to create a lung and a prostate plan. For each motion trace, the plan was delivered twice to a moving dosimeter; with and without real-time adaptation. Each measurement was compared to a static measurement and the percentage of failed points for gamma-tests recorded. Results: For all lung traces all measurement sets show improved dose accuracy with a mean 2%/2 mm gamma-fail rate of 1.6% with adaptation and 15.2% without adaptation (p < 0.001). For all prostate the mean 2%/2 mm gamma-fail rate was 1.4% with adaptation and 17.3% without adaptation (p < 0.001). The difference between the four systems was small with an average 2%/2 mm gamma-fail rate of <3% for all systems with adaptation for lung and prostate. Conclusions: The investigated systems all accounted for realistic tumor motion accurately and performed to a similar high standard, with real-time adaptation significantly outperforming non-adaptive delivery methods. KW - Robotic tracking KW - Gimbaled tracking KW - MLC tracking KW - Couch tracking KW - Organ motion Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-189605 VL - 119 IS - 1 ER - TY - JOUR A1 - Bonig, Halvard A1 - Kuçi, Zyrafete A1 - Kuçi, Selim A1 - Bakhtiar, Shahrzad A1 - Basu, Oliver A1 - Bug, Gesine A1 - Dennis, Mike A1 - Greil, Johann A1 - Barta, Aniko A1 - Kállay, Krisztián M. A1 - Lang, Peter A1 - Lucchini, Giovanna A1 - Pol, Raj A1 - Schulz, Ansgar A1 - Sykora, Karl-Walter A1 - Teichert von Luettichau, Irene A1 - Herter-Sprie, Grit A1 - Ashab Uddin, Mohammad A1 - Jenkin, Phil A1 - Alsultan, Abdulrahman A1 - Buechner, Jochen A1 - Stein, Jerry A1 - Kelemen, Agnes A1 - Jarisch, Andrea A1 - Soerensen, Jan A1 - Salzmann-Manrique, Emilia A1 - Hutter, Martin A1 - Schäfer, Richard A1 - Seifried, Erhard A1 - Paneesha, Shankara A1 - Novitzky-Basso, Igor A1 - Gefen, Aharon A1 - Nevo, Neta A1 - Beutel, Gernot A1 - Schlegel, Paul-Gerhardt A1 - Klingebiel, Thomas A1 - Bader, Peter T1 - Children and adults with Refractory acute Graft-versus-Host Disease respond to treatment with the Mesenchymal Stromal cell preparation “MSC-FFM”—Outcome report of 92 patients JF - Cells N2 - (1) Background: Refractory acute graft-versus-host disease (R-aGvHD) remains a leading cause of death after allogeneic stem cell transplantation. Survival rates of 15% after four years are currently achieved; deaths are only in part due to aGvHD itself, but mostly due to adverse effects of R-aGvHD treatment with immunosuppressive agents as these predispose patients to opportunistic infections and loss of graft-versus-leukemia surveillance resulting in relapse. Mesenchymal stromal cells (MSC) from different tissues and those generated by various protocols have been proposed as a remedy for R-aGvHD but the enthusiasm raised by initial reports has not been ubiquitously reproduced. (2) Methods: We previously reported on a unique MSC product, which was generated from pooled bone marrow mononuclear cells of multiple third-party donors. The products showed dose-to-dose equipotency and greater immunosuppressive capacity than individually expanded MSCs from the same donors. This product, MSC-FFM, has entered clinical routine in Germany where it is licensed with a national hospital exemption authorization. We previously reported satisfying initial clinical outcomes, which we are now updating. The data were collected in our post-approval pharmacovigilance program, i.e., this is not a clinical study and the data is high-level and non-monitored. (3) Results: Follow-up for 92 recipients of MSC-FFM was reported, 88 with GvHD ≥°III, one-third only steroid-refractory and two-thirds therapy resistant (refractory to steroids plus ≥2 additional lines of treatment). A median of three doses of MSC-FFM was administered without apparent toxicity. Overall response rates were 82% and 81% at the first and last evaluation, respectively. At six months, the estimated overall survival was 64%, while the cumulative incidence of death from underlying disease was 3%. (4) Conclusions: MSC-FFM promises to be a safe and efficient treatment for severe R-aGvHD. KW - graft-versus host KW - transplantation KW - mesenchymal stromal cell KW - cell therapy KW - hospital exemption KW - steroid-resistant aGvHD KW - refractory aGvHD Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-193878 SN - 2073-4409 VL - 8 IS - 12 ER - TY - JOUR A1 - Lamberger, Zan A1 - Zainuddin, Shakir A1 - Scheibel, Thomas A1 - Lang, Gregor T1 - Polymeric Janus Fibers JF - ChemPlusChem N2 - Janus fibers are a class of composite materials comprising mechanical and chemical to biological functionality. Combining different materials and functionalities in one micro- or even nanoscale fiber enables otherwise unreachable synergistic physicochemical effects with unprecedented opportunities for technical or biomedical applications. Here, recent developments of processing technologies and applications of polymeric Janus fibers will be reviewed. Various examples in the fields of textiles, catalysis, sensors as well as medical applications, like drug delivery systems, tissue engineering and antimicrobial materials, are presented to illuminate the outstanding potential of such high-end functional materials for novel applications in the upcoming future. KW - hybrid materials KW - polymers KW - nanofibers KW - spinning KW - Janus fibers Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-318516 VL - 88 IS - 2 ER - TY - JOUR A1 - Lang, Stefan J. A1 - Messmer, Elisabeth M. A1 - Geerling, Gerd A1 - Mackert, Marc J. A1 - Brunner, Tobias A1 - Dollak, Sylvia A1 - Kutchoukov, Borislav A1 - Böhringer, Daniel A1 - Reinhard, Thomas A1 - Maier, Philip T1 - Prospective, randomized, double-blind trial to investigate the efficacy and safety of corneal cross-linking to halt the progression of keratoconus JF - BMC Ophthalmology N2 - Background: Corneal cross-linking is widely used to treat keratoconus. However, to date, only limited data from randomized trials support its efficacy. Methods: The efficacy and safety of corneal cross-linking for halting progression of keratoconus were investigated in a prospective, randomized, blinded, placebo controlled, multicentre trial. Twenty-nine keratoconus patients were randomized in three trial centres. The mean age at inclusion was 28 years. Longitudinal changes in corneal refraction were assessed by linear regression. The best corrected visual acuity, surface defects and corneal inflammation were also assessed. These data were analysed with a multifactorial linear regression model. Results: A total of 15 eyes were randomized to the treatment and 14 to the control group. Follow-up averaged 1098 days. Corneal refractive power decreased on average (+/-standard deviation) by 0.35 +/- 0.58 dioptres/year in the treatment group. The controls showed an increase of 0.11 +/- 0.61 dioptres/year. This difference was statistically significant (p = 0.02). Conclusions: Our data suggest that corneal cross-linking is an effective treatment for some patients to halt the progression of keratoconus. However, some of the treated patients still progressed, whereas some untreated controls improved. Therefore, further investigations are necessary to decide which patients require treatment and which do not. KW - ultraviolet-a KW - riboflavin KW - Scheimpflug KW - eyes KW - haze Y1 - 2015 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-151498 VL - 15 IS - 78 ER -